Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Powsner, J. Costa, R. Homer (2000)
Clinicians are from Mars and pathologists are from Venus.Archives of pathology & laboratory medicine, 124 7
V. Prasad, J. Lenzer, D. Newman (2016)
Why cancer screening has never been shown to “save lives”—and what we can do about itBMJ : British Medical Journal, 352
Jaquelyn Jahn, E. Giovannucci, M. Stampfer (2015)
The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate‐specific Antigen‐eraInternational Journal of Cancer, 137
A. Miyauchi, Yasuhiro Ito, H. Oda (2018)
Insights into the Management of Papillary Microcarcinoma of the ThyroidThyroid, 28
Kirsten Bibbins-Domingo, D. Grossman, S. Curry (2017)
The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment.JAMA, 317 19
A. Bill-Axelson, Lars Holmberg, Mirja Ruutu, H. Garmo, Jennifer Stark, Christer Busch, Stig Nordling, M. Häggman, S. Andersson, S. Bratell, Anders Spångberg, Juni Palmgren, Gunnar Steineck, Hans-Olov Adami, Jan-Erik Johansson (2005)
Radical prostatectomy versus watchful waiting in early prostate cancer.The New England journal of medicine, 364 18
L. Esserman, I. Thompson, B. Reid, P. Nelson, D. Ransohoff, H. Welch, S. Hwang, D. Berry, K. Kinzler, W. Black, M. Bissell, H. Parnes, S. Srivastava (2014)
Addressing overdiagnosis and overtreatment in cancer: a prescription for change.The Lancet. Oncology, 15 6
Hyemi Kwon, Hye-Seon Oh, Mijin Kim, Suyeon Park, M. Jeon, Won Kim, W. Kim, Y. Shong, D. Song, J. Baek, K. Chung, Tae Kim (2017)
Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center’s Experience in KoreaThe Journal of Clinical Endocrinology & Metabolism, 102
L. Esserman, I. Thompson, B. Reid (2013)
Overdiagnosis and overtreatment in cancer: an opportunity for improvement.JAMA, 310 8
Xiaopei Shen, Guangwu Zhu, Rengyun Liu, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C. O'Neill, M. Sywak, R. Clifton-Bligh, B. Bendlova, V. Sykorova, Mingzhao Xing (2017)
Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36 5
R. Tuttle, B. Haugen, N. Perrier (2017)
Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?Thyroid : official journal of the American Thyroid Association, 27 6
G. Gin, Jorge Pereira, A. Weinberg, R. Mehrazin, S. Lerner, J. Sfakianos, C. Phillips (2016)
Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: A survey of U.S. transplantation centers.Urologic oncology, 34 2
F. Schröder, J. Hugosson, M. Roobol, T. Tammela, S. Ciatto, V. Nelen, M. Kwiatkowski, M. Luján, H. Lilja, M. Zappa, L. Denis, F. Recker, A. Berenguer, L. Määttänen, C. Bangma, G. Aus, A. Villers, X. Rébillard, T. Kwast, B. Blijenberg, S. Moss, H. Koning, A. Auvinen (2009)
Screening and prostate-cancer mortality in a randomized European study.The New England journal of medicine, 360 13
Kirsten Bibbins-Domingo, D. Grossman, S. Curry, M. Barry, K. Davidson, Chyke Doubeni, J. Epling, A. Kemper, A. Krist, A. Kurth, C. Landefeld, C. Mangione, M. Phipps, Michael Silverstein, M. Simon, A. Siu, Chien-Wen Tseng (2017)
Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation StatementJAMA, 317
A. Aizer, J. Paly, A. Zietman, P. Nguyen, C. Beard, S. Rao, I. Kaplan, A. Niemierko, M. Hirsch, Chin-Lee Wu, A. Olumi, M. Michaelson, A. D'Amico, J. Efstathiou (2012)
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 25
T. Stephens (2011)
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation StatementYearbook of Diagnostic Radiology, 2011
I. Hay, Maeve Hutchinson, T. Gonzalez-Losada, B. Mciver, Megan Reinalda, C. Grant, G. Thompson, T. Sebo, J. Goellner (2008)
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.Surgery, 144 6
S. Vaccarella, S. Franceschi, F. Bray, C. Wild, M. Plummer, L. Maso (2016)
Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.The New England journal of medicine, 375 7
Tina Fan, Ruth Stefanos (2021)
Screening for Colorectal Cancer.American family physician, 104 3
A. Popadich, O. Levin, James Lee, Stephanie Smooke-Praw, Kevin Ro, M. Fazel, A. Arora, N. Tolley, F. Palazzo, D. Learoyd, S. Sidhu, L. Delbridge, M. Sywak, M. Yeh (2011)
A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.Surgery, 150 6
H. Oda, A. Miyauchi, Yasuhiro Ito, Kana Yoshioka, Ayako Nakayama, Hisanori Sasai, H. Masuoka, T. Yabuta, M. Fukushima, T. Higashiyama, M. Kihara, Kaoru Kobayashi, A. Miya (2016)
Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate SurgeryThyroid, 26
A. Ho, L. Davies, I. Nixon, Frank Palmer, Laura Wang, S. Patel, I. Ganly, R. Wong, R. Tuttle, L. Morris (2015)
Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival ratesCancer, 121
A. Burnett (2005)
Erectile dysfunction following radical prostatectomy.JAMA, 293 21
M. Cooperberg, A. Vickers, J. Broering, Peter Carroll (2010)
Comparative risk‐adjusted mortality outcomes after primary surgery, radiotherapy, or androgen‐deprivation therapy for localized prostate cancerCancer, 116
K. Ritter, Dawn Elfenbein, David Schneider, Herb Chen, R. Sippel (2015)
Hypoparathyroidism after total thyroidectomy: incidence and resolution.The Journal of surgical research, 197 2
Thomas McCORMICK, Becky Conley (1995)
Patients' perspectives on dying and on the care of dying patients.The Western journal of medicine, 163 3
I. Sugitani, K. Toda, Keiko Yamada, N. Yamamoto, M. Ikenaga, Y. Fujimoto (2010)
Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and OutcomesWorld Journal of Surgery, 34
D. Clouston, D. Bolton (2012)
In situ and intraductal epithelial proliferations of prostate: Definitions and treatment implications Part 1: Prostatic intraepithelial neoplasiaBJU International, 109
L. Enewold, K. Zhu, E. Ron, A. Marrogi, A. Stojadinovic, G. Peoples, S. Devesa (2009)
Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005Cancer Epidemiology Biomarkers & Prevention, 18
L. Taylor, S. Canfield, Xianglin Du (2009)
Review of major adverse effects of androgen‐deprivation therapy in men with prostate cancerCancer, 115
Lane (2016)
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.BJU Int, 118
L. Klotz, D. Vesprini, P. Sethukavalan, V. Jethava, Liying Zhang, S. Jain, Toshihiro Yamamoto, A. Mamedov, A. Loblaw (2015)
Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 3
Jianyu Liu, Paul Womble, S. Merdan, David Miller, J. Montie, B. Denton (2015)
Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer.Urology, 86 5
M. Amin, S. Edge, F. Greene, D. Byrd, R. Brookland, M. Washington, J. Gershenwald, C. Compton, K. Hess, D. Sullivan, J. Jessup, J. Brierley, L. Gaspar, R. Schilsky, C. Balch, D. Winchester, Elliot Asare, M. Madera, Donna Gress, L. Meyer (2002)
AJCC Cancer Staging Manual
R. Tuttle, J. Fagin, G. Minkowitz, R. Wong, Benjamin Roman, S. Patel, B. Untch, I. Ganly, A. Shaha, Jatin Shah, M. Pace, Duan Li, A. Bach, O. Lin, Adrian Whiting, R. Ghossein, I. Landa, M. Sabra, L. Boucai, S. Fish, L. Morris (2017)
Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active SurveillanceJAMA Otolaryngology–Head & Neck Surgery, 143
Y. Nikiforov, R. Seethala, G. Tallini, Z. Baloch, F. Basolo, L. Thompson, J. Barletta, B. Wenig, A. Ghuzlan, K. Kakudo, T. Giordano, V. Alves, E. Khanafshar, S. Asa, A. El-Naggar, W. Gooding, S. Hodak, R. Lloyd, G. Maytal, O. Mete, M. Nikiforova, V. Nosé, M. Papotti, D. Poller, P. Sadow, A. Tischler, R. Tuttle, Kathryn Wall, V. Livolsi, G. Randolph, R. Ghossein (2016)
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.JAMA oncology, 2 8
T. Daskivich, K. Fan, T. Koyama, P. Albertsen, M. Goodman, A. Hamilton, R. Hoffman, J. Stanford, A. Stroup, M. Litwin, D. Penson (2013)
Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population–Based Cohort of Men With Prostate CancerAnnals of Internal Medicine, 158
Jillian Henderson, Elizabeth Webber, G. Sawaya (2016)
Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task ForceJAMA, 319
M. Cooperberg, P. Carroll (2015)
Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.JAMA, 314 1
E. Cibas, Syed Ali (2017)
The 2017 Bethesda System for Reporting Thyroid Cytopathology.Thyroid : official journal of the American Thyroid Association, 27 11
Jahn (2015)
The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the prostate-specific antigen-era.Int J Cancer, 137
Bibbins-Domingo (2016)
Screening for colorectal cancer: US Preventive Services Task Force recommendation statement.JAMA, 315
L. Davies, H. Welch (2014)
Current thyroid cancer trends in the United States.JAMA otolaryngology-- head & neck surgery, 140 4
Yasuhiro Ito, A. Miyauchi, H. Inoue, M. Fukushima, M. Kihara, T. Higashiyama, C. Tomoda, Y. Takamura, Kaoru Kobayashi, A. Miya (2009)
An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese PatientsWorld Journal of Surgery, 34
T. Wilt, Karen Jones, M. Barry, G. Andriole, D. Culkin, T. Wheeler, W. Aronson, M. Brawer (2017)
Follow‐up of Prostatectomy versus Observation for Early Prostate CancerThe New England Journal of Medicine, 377
Karen Scherr, A. Fagerlin, T. Hofer, Laura Scherer, M. Holmes-Rovner, Lillie Williamson, Valerie Kahn, J. Montgomery, Kirsten Greene, Biqi Zhang, P. Ubel (2017)
Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment DecisionsMedical Decision Making, 37
Yasuhiro Ito, A. Miyauchi (2007)
A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroidNature Clinical Practice Endocrinology &Metabolism, 3
E. Mazzaferri (2007)
Management of low-risk differentiated thyroid cancer.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 13 5
R. Otto, V. Lawrence, R. Dobie, C. Sakai (1997)
Impact of a Laryngectomy on Quality of Life: Perspective of the Patient versus That of the Health Care ProviderAnnals of Otology, Rhinology & Laryngology, 106
J. Epstein, Zhaoyong Feng, B. Trock, P. Pierorazio (2012)
Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.European urology, 61 5
E. Mazzaferri (1993)
Management of a solitary thyroid nodule.The New England journal of medicine, 328 8
J. Fenton, M. Weyrich, Shauna Durbin, Yu Liu, H. Bang, J. Melnikow (2018)
Prostate-Specific Antigen–Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task ForceJAMA, 319
H. Verloop, M. Louwerens, J. Schoones, J. Kievit, J. Smit, O. Dekkers (2012)
Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies.The Journal of clinical endocrinology and metabolism, 97 7
L. Hurtado-López, Maria Pacheco-Alvarez, M. Montes-Castillo, Felipe Zaldívar‐Ramírez (2005)
Importance of the intraoperative identification of the external branch of the superior laryngeal nerve during thyroidectomy: electromyographic evaluation.Thyroid : official journal of the American Thyroid Association, 15 5
Jennifer Lin, E. Bowles, Selvi Williams, Caitlin Morrison (2017)
Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task ForceJAMA, 317
N. Iyer, L. Morris, R. Tuttle, A. Shaha, I. Ganly (2011)
Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapyCancer, 117
G. Andriole, E. Crawford, R. Grubb, S. Buys, D. Chia, T. Church, M. Fouad, E. Gelmann, P. Kvale, D. Reding, J. Weissfeld, L. Yokochi, B. O'Brien, J. Clapp, J. Rathmell, T. Riley, R. Hayes, Barnett Kramer, G. Izmirlian, A. Miller, P. Pinsky, P. Prorok, J. Gohagan, C. Berg (2009)
Mortality results from a randomized prostate-cancer screening trial.The New England journal of medicine, 360 13
N. Saquib, J. Saquib, J. Ioannidis (2015)
Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials.International journal of epidemiology, 44 1
NickelBrooke, P. BritoJuan, BarrattAlexandra, JordanSusan, MoynihanRay, McCafferyKirsten (2017)
Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.Thyroid, 27
L. Esserman, Yiwey Shieh, I. Thompson (2009)
Rethinking screening for breast cancer and prostate cancer.JAMA, 302 15
D. Grossman, S. Curry, D. Owens, Kirsten Bibbins-Domingo, A. Caughey, K. Davidson, Chyke Doubeni, M. Ebell, J. Epling, A. Kemper, A. Krist, Martha Kubik, C. Landefeld, C. Mangione, Michael Silverstein, M. Simon, A. Siu, Chien-Wen Tseng (2018)
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation StatementJAMA, 319
T. D’Agostino, Elyse Shuk, E. Maloney, Rebecca Zeuren, R. Tuttle, Carma Bylund (2018)
Treatment decision making in early‐stage papillary thyroid cancerPsycho‐Oncology, 27
Siu (2016)
Screening for breast cancer: US Preventive Services Task Force recommendation statement.Ann Intern Med, 164
F. Hamdy, J. Donovan, J. Lane, M. Mason, C. Metcalfe, P. Holding, M. Davis, Tim Peters, E. Turner, Richard Martin, J. Oxley, M. Robinson, J. Staffurth, E. Walsh, P. Bollina, J. Catto, A. Doble, A. Doherty, D. Gillatt, R. Kockelbergh, H. Kynaston, A. Paul, P. Powell, S. Prescott, D. Rosario, E. Rowe, D. Neal, D. Neal (2017)
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.The New England journal of medicine, 375 15
B. Nickel, J. Brito, A. Barratt, S. Jordan, R. Moynihan, K. McCaffery (2017)
Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.Thyroid : official journal of the American Thyroid Association, 27 5
H. Ahn, H. Kim, H. Welch (2014)
Korea's thyroid-cancer "epidemic"--screening and overdiagnosis.The New England journal of medicine, 371 19
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, A. Murugan, Guangwu Zhu, M. Zeiger, S. Pai, J. Bishop (2014)
BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 25
B. Haugen, E. Alexander, K. Bible, Gerard Doherty, S. Mandel, Y. Nikiforov, F. Pacini, G. Randolph, Anna Sawka, M. Schlumberger, K. Schuff, S. Sherman, J. Sosa, D. Steward, R. Tuttle, L. Wartofsky (2009)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.Thyroid : official journal of the American Thyroid Association, 26 1
A. Miyauchi, Takumi Kudo, Yasuhiro Ito, H. Oda, Hisanori Sasai, T. Higashiyama, M. Fukushima, H. Masuoka, M. Kihara, A. Miya (2018)
Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillanceSurgery, 163
M. Sanda, J. Cadeddu, Erin Kirkby, Ronald Chen, Tony Crispino, J. Fontanarosa, S. Freedland, Kirsten Greene, L. Klotz, D. Makarov, J. Nelson, G. Rodrigues, H. Sandler, M. Taplin, J. Treadwell (2017)
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care OptionsThe Journal of Urology, 199
T. Freedman, H. Lynch, S. Lemon, S. Tinley, J. Lynch, P. Watson (1997)
Psychologic Aspects of Cancer Genetic Testing: A Research Update for Clinicians
J. Tosoian, M. Mamawala, J. Epstein, P. Landis, S. Wolf, B. Trock, H. Carter (2015)
Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 30
V. Moyer (2012)
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 157
A. Vellekoop, S. Loeb (2013)
More aggressive prostate cancer in elderly men.Reviews in urology, 15 4
A. Lane, C. Metcalfe, G. Young, T. Peters, J. Blazeby, K. Avery, D. Dedman, L. Down, M. Mason, D. Neal, F. Hamdy, J. Donovan, S. Bonnington, L. Bradshaw, D. Cooper, E. Elliott, Pippa Herbert, P. Holding, J. Howson, Mandy Jones, T. Lennon, N. Lyons, Hilary Moody, Claire Plumb, T. O'Sullivan, L. Salter, S. Tidball, P. Thompson, Tonia Adam, S. Askew, S. Atkinson, T. Baynes, J. Blaikie, C. Brain, Vivienne Breen, S. Brunt, S. Bryne, Jo Bythem, Jenny Clarke, Jenny Cloete, S. Dark, Gill Davis, Rachael Rue, Jane Denizot, Elspeth Dewhurst, Anna Dimes, N. Dixon, Penny Ebbs, I. Emmerson, J. Ferguson, A. Gadd, L. Geoghegan, A. Grant, Collette Grant, Catherine Gray, Rosemary Godfrey, L. Goodwin, Susie Hall, Liz Hart, A. Harvey, C. Hoult, S. Hawkins, S. Holling, A. Innes, S. Kilner, Fiona Marshall, L. Mellen, A. Moore, S. Napier, Julie Needham, Kevin Pearse, A. Pisa, M. Rees, Elliw Richards, Lindsay Robson, J. Roxburgh, Nikki Samuel, Irene Sharkey, M. Slater, Donna Smith, Pippa Taggart, H. Taylor, Vicky Taylor, Ayesha Thomas, Briony Tomkies, Nicola Trewick, C. Ward, C. Walker, Ayesha Williams, Colin Woodhouse, Elizabeth Wyber, J. Aning, P. Bollina, J. Catto, A. Doble, A. Doherty, G. Durkan, D. Gillatt, O. Hughes, Roger Kocklebergh, Anthony Kouparis, H. Kynaston, H. Leung, P. Mariappan, A. McNeill, E. Páez, A. Paul, R. Persad, P. Powell, S. Prescott, D. Rosario, E. Rowe, H. Schwaibold, David Tulloch, M. Wallace, A. Bahl, Richard Benson, M. Beresford, C. Ferguson, J. Graham, Chris Herbert, G. Howard, N. James, A. Law, C. Loughrey, Duncan McClaren, H. Patterson, I. Pedley, A. Robinson, S. Russell, J. Staffurth, P. Symonds, N. Thanvi, S. Vasanthan, P. Wilson, H. Appleby, Dominic Ash, D. Aston, Stevens Bolton, Graham Chalmers, J. Conway, Nick Early, Tony Geater, Lynda Goddall, C. Heymann, D. Hicks, Lizard Jones, S. Lamb, G. Lambert, G. Lawrence, G. Lewis, J. Lilley, Aileen MacLeod, P. Massey, A. McQueen, Rollo Moore, L. Penketh, J. Potterton, N. Roberts, H. Showler, S. Slade, Alasdair Steele, J. Swinscoe, M. Tiffany, J. Townley, J. Treeby, Joyce Wilkinson, L. Williams, L. Wills, O. Woodley, S. Yarrow, S. Bhattarai, Neeta Deshmukh, J. Dormer, Malee Fernando, J. Goepel, D. Griffiths, K. Grigor, N. Mayer, J. Oxley, M. Robinson, M. Varma, A. Warren, L. Brindle, M. Davis, Hanan Khazragui, S. Noble, H. Taylor, Marta Tazewell, E. Turner, J. Wade, E. Walsh, S. Baker, Elizabeth Bellis‐Sheldon, Chantal Bougard, J. Bowtell, Catherine Brewer, C. Burton, J. Charlton, N. Christoforou, Rebecca Clark, S. Coull, C. Croker, Rosemary Currer, Claire Daisey, G. Delaney, Rose Donohue, Jane Drew, Rebecca Farmer, Susann Fry, J. Haddow, A. Hale, S. Halpin, B. Harris, Barbara Hattrick, Sharon Holmes, Helen Hunt, Vicky Jackson, Donna Johnson, Mandy Butt, J. Leworthy, Tanya Liddiatt, Alex Martin, Jainee Mauree, S. Moore, Gill Moulam, J. Mutch, Alena Nash, Kathleen Parker, C. Pawsey, Michelle Purdie, T. Robson, Lynne Smith, Joost-Willem Snoeck, C. Stenton, Tom Steuart‐Feilding, C. Sully, C. Sutton, Carol Torrington, Zoe Wilkins, Sharon Williams, A. Wilson, A. Grant, Ian Roberts, D. Ashby, R. Cowan, P. Fayers, K. Mellon, J. N'Dow, T. O'brien, Michael Sokhal, M. Baum, J. Adolfson, P. Albertsen, D. Dearnaley, F. Schroeder, Tracy Roberts, A. Zietman (2016)
Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of lifeBju International, 118
L. Harris, A. Cooper, K. Rasinski, F. Curlin, A. Lyerly (2011)
Obstetrician–Gynecologists' Objections to and Willingness to Help Patients Obtain an AbortionObstetrics & Gynecology, 118
H. Orom, D. Homish, G. Homish, W. Underwood (2014)
Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.Urologic oncology, 32 4
Insoo Suh, M. Vriens, M. Guerrero, A. Griffin, W. Shen, Q. Duh, O. Clark, E. Kebebew (2010)
Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid.American journal of surgery, 200 1
Yasuhiro Ito, A. Miyauchi, M. Kihara, T. Higashiyama, Kaoru Kobayashi, A. Miya (2014)
Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.Thyroid : official journal of the American Thyroid Association, 24 1
ImportanceAcross many countries, a rapid escalation of the incidence of thyroid cancer has been observed, a surge that nonetheless underestimates the true extent of the disease. Most thyroid cancers now diagnosed comprise small, low-risk cancers that are incidentally found and are unlikely to cause harm. In many ways, prostate cancer similarly harbors a well-behaved subclinical reservoir, a long natural history, and superlative outcomes that have made active surveillance the de facto guideline recommendation for low-risk disease. This review highlights the parallels and differences between prostate cancer and thyroid cancer regarding screening, diagnosis, risk stratification, and considerations for active surveillance. ObservationsProstate cancer and thyroid cancer have undergone recalibrated, de-escalatory shifts to counter changing epidemiologic landscapes. The US Preventive Services Task Force has issued cautionary recommendations on screening via prostate-specific antigen testing or neck ultrasonography, while the thresholds to performing biopsy have increased. Comparable changes to cancer terminology and staging have also helped alleviate patient anxiety and minimize pressure for overtreatment. Long-term, randomized prospective clinical trials for prostate cancer have established active surveillance as a first-line treatment approach for properly stratified low-risk patients, while observational trials for thyroid cancer have also made strides in defining risk and eligibility for surgery. Caveats requiring deeper investigation include aggressive disease in older patients, underestimation of the extent of the disease, and patient-physician bias in shared decision making. For prostate cancer, survival may not improve and function will likely worsen after intervention; for thyroid cancer, patients are younger, surgery is safer, and the bar for surveillance will likely be higher. Conclusions and RelevanceDespite similarities in biological indolence between low-risk prostate and thyroid malignant neoplasms, key distinctions in life expectancy and treatment sequelae may ultimately confer somewhat disparate management paradigms for the 2 diseases. Nevertheless, the experience forged by prostate cancer trials serves as a model for thyroid cancer management, potentially reshaping the perception of active surveillance into a credible, valuable treatment modality.
JAMA Oncology – American Medical Association
Published: Apr 13, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.